At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
The Executive Director, EDPLs bring an even more advanced experience base to the role in, amongst other things, having demonstrated proficiency in leading across multiple functional boundaries on a range of exploratory development assets with complex strategies to accelerate effective decision-making. These individuals will be responsible for oversight of multiple assets within the Immunology portfolio, at various stages of the development continuum from Discovery to POC, and encompassing small molecules, biologics, and possibly cellular therapies. In addition, responsibilities may including involvement with business development opportunities to help shape future immunology portfolio, and leading broader departmental and enterprise-wide initiatives.
Strategy & Execution
Uses an understanding of immunology, disease biology, the early-stage drug development process (particularly cross-functional connectivity), and relevant late-stage challenges (e.g., trends in disease area therapeutic advances, and evolving regulatory, patient advocacy and market access environments) to create a vision for each asset, then design and execute effective exploratory development programs in support of the overall R&D portfolio goals.
Effectively engages cross company expertise and utilizes advisory groups and governance bodies (eg, TRCs, REDOC, PSGT) to define, revise and champion asset development strategies and implementation plans.
Continually analyzes progress, engages in critical thinking, and asserts strong problem-solving toward delivering key data and interpretation essential for robust debate and rapid, data-driven decision making on assigned projects.
Delivers high quality assets to Full Development which have the potential for a competitive profile to address the unmet medical needs of patients and to provide favorable shareholder return.
Ensures the process and output of the team meets established program standards (per PD&C Process expectations (i.e., BMS Governance process), within budget, on schedule, compliant, etc.), while also looking for opportunities to streamline development and enable continuous improvements without compromising quality.
Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans with functional area capabilities, and clearly communicates program risks, implications of changes in the competitive landscape and progress toward key milestones.
Leadership & Matrix Alignment
Drug development professional, able to bring broad, multi-disciplinary experiences to the challenges and opportunities of new targets and new molecules.
Forward looking, objective matrix leader with demonstrated ability to frame issues, ask the right clarifying questions, and rationalize decisions in a cost-disciplined manner, with an enterprise view.
Experience/judgment to efficiently integrate information from team members/key advisors to facilitate making rapid and objective, data-driven decisions.
Sets goals and objectives for asset development; ensures aligned functional and individual objectives (for self and team members) across the BMS matrix to accomplish the asset development plan.
Oversees relevant sub-teams and ensures clear goals and performance standards are in place, provides feedback and coaching, appropriately delegates responsibilities, and holds sub-team leaders accountable for key deliverables.
Builds, proactively manages, and professionally develops a high performing team with diverse perspectives
Builds productive peer-to-peer relationships with TRC leaders and functional heads of all groups that interact with the EDPL organization to ensure optimal functional area cooperation and resource support needed for optimal delivery on R&ED goals and overall portfolio priorities.
Serves as a coach/mentor to other EDPLs
MD, PhD, DVM, PharmD or equivalent advanced degree of relevance.
Experienced drug developer with at least 10 years' experience in the drug development process, with particular in-depth know how and experience in the early development space and matrix team leadership.
Deep understanding of the role of basic biology, pharmaceutical optimization, translational medicine, and clinical pharmacology, including exposure-response relationships and dose selection in early development.
Strong understanding of relevant regulatory health authority expectations and regulations for drug development, with a focus on early development but with an understanding of implications toward full development.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Bristol Myers Squibb